Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 10
Open access
2,266
Views
1
CrossRef citations to date
0
Altmetric
Original Articles
Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials
Inna Y. Gonga Department of Radiation Medicine, University of Toronto, Toronto, Ontario, CanadaView further author information
, Mahmood Aminilarib Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, CanadaView further author information
, Ivan Landegoc Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, CanadaView further author information
, Katrina Huenikenb Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, CanadaView further author information
, Qianghua Zhoud Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
https://orcid.org/0000-0001-7483-0478View further author information
John Kuruvillaa Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada;c Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
https://orcid.org/0000-0002-6117-320XView further author information
David C. Hodgsona Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada;b Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-4687-4582View further author information
Pages 1643-1654
|
Received 06 Apr 2023, Accepted 30 Jun 2023, Published online: 07 Aug 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.